Company profilePharmaceutical#385 of 1,318 in Pakistan1 DRAP alert

PHARMIX LABORATORIES (PRIVATE) LIMITED.

Pharmaceutical company · 44 brands · 50 molecules

Ranked #208 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

44 registered products 12 pharmaceutical brands 50 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

PHARMIX LABORATORIES (PRIVATE) LIMITED. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 44 product registrations across 50 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antiemetics & Antinauseants. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by PHARMIX

5 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Allergy 2

Alergo10mgRs 150 LORATE10MGRs 128.3

Antiemetics & Antinauseants 1

Emidone10mgRs 53.6

Pain Management 1

Provin500mgRs 216.4

Other 1

Myosoft4mgRs 16.97

Top molecules by brand count

Famotidine1 brand

Thiocolchicoside1 brand

Naproxen1 brand

Artemether1 brand

Lumefantrine1 brand

Domperidone1 brand

Cetirizine1 brand

Iron Protein Succinylate1 brand

Alprazolam1 brand

Gabapentin1 brand

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official1 products · Rs 587.28 – Rs 587.28

DVAGO3 products · Rs 16.97 – Rs 128.3

Servaid3 products · Rs 109.9 – Rs 216.4

Median across source: Rs 150

Regulatory record

1 alert in the DRAP feed we track.

Recall Alert; Drug Product: Recall of Liquid Preparations for Suspected Contamination of D

2023-11-16

Competitive set

Companies whose registered portfolio overlaps most with this one.

Wilshire Laboratories (Private) Limited21 shared molecules

SEARLE PAKISTAN (PVT.) LTD.16 shared molecules

SHROOQ PHARMACEUTICALS16 shared molecules

GENOME PHARMACEUTICALS (PVT) LTD16 shared molecules

NEUTRO PHARMA (PVT) LTD.15 shared molecules

BIO LABS (PVT) LTD.15 shared molecules

VALOR PHARMACEUTICALS15 shared molecules

ENGLISH PHARMACEUTICALS INDUSTRIES15 shared molecules

SIZA INTERNATIONAL (PVT) LTD.15 shared molecules

GLOBAL BRANDS DISTRIBUTORS14 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 131 molecules not in this portfolio

SEARLE PAKISTAN (PVT.) LTD. holds 236 molecules not in this portfolio

SHROOQ PHARMACEUTICALS holds 21 molecules not in this portfolio

Get the full profile for PHARMIX

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included